Literature DB >> 27623788

CORR Insights®: What Risks are Associated with Primary THA in Recipients of Hematopoietic Stem Cell Transplantation?

Ran Schwarzkopf1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27623788      PMCID： PMC5213941          DOI： 10.1007/s11999-016-5080-0

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  6 in total

1.  Osteonecrosis of the femoral head after allogeneic bone marrow transplantation.

Authors:  Y Torii; Y Hasegawa; T Kubo; Y Kodera; S Minami; Y Morishita; Y Yamada; H Iwata
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

2.  Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM).

Authors:  G Socié; J Y Cahn; J Carmelo; J P Vernant; J P Jouet; N Ifrah; N Milpied; M Michallet; B Lioure; J L Pico; F Witz; L Molina; A Fischer; V J Bardou; E Gluckman; J Reiffers
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

3.  Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation.

Authors:  H Enright; R Haake; D Weisdorf
Journal:  Am J Med       Date:  1990-12       Impact factor: 4.965

4.  Avascular necrosis following bone marrow transplantation: a case-control study.

Authors:  J C Fink; W M Leisenring; K M Sullivan; D J Sherrard; N S Weiss
Journal:  Bone       Date:  1998-01       Impact factor: 4.398

5.  Osteonecrosis after allogeneic bone marrow transplantation.

Authors:  Frederic Zadegan; Agnes Raould; Pascal Bizot; Remy Nizard; Laurent Sedel
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

6.  Survivorship After Primary Total Hip Arthroplasty in Solid-Organ Transplant Patients.

Authors:  Brian P Chalmers; Cameron K Ledford; Joseph M Statz; Kevin I Perry; Tad M Mabry; Arlen D Hanssen; Matthew P Abdel
Journal:  J Arthroplasty       Date:  2016-04-28       Impact factor: 4.757
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.